|
1.
|
|
5 p, 470.9 KB |
Spanish Cell Therapy Network (TerCel) : 15 years of successful collaborative translational research
/
Sánchez-Guijo, Fermín (Universidad de Salamanca) ;
García-Olmo, Damián (Universidad Autónoma de Madrid) ;
Prósper, Felipe (Universidad de Navarra) ;
Martínez, Salvador (Instituto de Neurociencias UMH-CSIC) ;
Zapata, Agustín (Universidad Complutense de Madrid) ;
Fernandez Aviles, Francesc (IiSGM-Hospital General Universitario Gregorio Marañón) ;
Toledo-Aral, Juan José (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Torres, Miguel (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Fariñas, Isabel (Universitat de València) ;
Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ;
Labandeira-García, José Luis (Universidade de Santiago de Compostela) ;
García-Sancho, Javier (Universidad de Valladolid) ;
Moraleda, José M. (Universidad de Murcia) ;
Universitat Autònoma de Barcelona
In the current article we summarize the 15-year experience of the Spanish Cell Therapy Network (TerCel), a successful collaborative public initiative funded by the Spanish government for the support of nationwide translational research in this important area. [...]
2020 -  10.1016/j.jcyt.2019.11.001
Cytotherapy, Vol. 22 Núm. 1 (january 2020) , p. 1-5
|
|
|
2.
|
|
8 p, 1.1 MB |
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis : Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model
/
Hernandez-Boluda, Juan Carlos (Universitat de València) ;
Pereira, Arturo (Hospital Clínic i Provincial de Barcelona) ;
Álvarez Larrán, Alberto (Hospital Clínic i Provincial de Barcelona) ;
Martín, Ana Africa (Hospital Universitario de Salamanca) ;
Benzaquen, Ana (Universitat de València) ;
Aguirre, Lourdes (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Mora, Elvira (Hospital Universitari i Politècnic La Fe (València)) ;
González, Pedro (Hospital Universitario Virgen de las Nieves (Granada)) ;
Mora, Jorge (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Dorado, Nieves (Hospital General Universitario Gregorio Marañón) ;
Sampol, Antonia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
García-Gutiérrez, Valentín (Hospital Universitario Ramón y Cajal (Madrid)) ;
López-Godino, Oriana (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Fox, Maria Laura (Hospital Universitari Vall d'Hebron) ;
Reguera, Juan Luis (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Pérez-Encinas, Manuel (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Pascual, María Jesús (Hospital Regional Universitario Carlos Haya (Málaga)) ;
Xicoy, Blanca (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Parody, Rocío (Institut Català d'Oncologia) ;
González-Pinedo, Leslie (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Español, Ignacio (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Avendaño, Alejandro (Hospital Universitario de Salamanca) ;
Correa, Juan Gonzalo (Hospital Clínic i Provincial de Barcelona) ;
Vallejo, Carlos (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Jurado, Manuel (Hospital Universitario Virgen de las Nieves (Granada)) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Osorio, Santiago (Hospital General Universitario Gregorio Marañón) ;
Durán, María Antonia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Sanchez-Guijo, Fermin (Hospital Universitario de Salamanca) ;
Cervantes, Francisco (Hospital Clínic i Provincial de Barcelona) ;
Piñana, José Luis (Hospital Universitari i Politècnic La Fe (València)) ;
Universitat Autònoma de Barcelona
Accurate prognostic tools are crucial to assess the risk/benefit ratio of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with myelofibrosis (MF). We aimed to evaluate the performance of the Myelofibrosis Transplant Scoring System (MTSS) and identify risk factors for survival in a multicenter series of 197 patients with MF undergoing allo-HCT. [...]
2020 - 10.1016/j.bbmt.2020.07.022
Biology of blood and marrow transplantation, Vol. 26 Núm. 12 (december 2020) , p. 2237-2244
|
|
|
3.
|
|
|
4.
|
|
2 p, 458.6 KB |
Role of Hospital Exemption in Europe : position paper from the Spanish Advanced Therapy Network
/
Sanchez-Guijo, Fermin (Universidad de Salamanca) ;
Badimon, Lina (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Avendaño Sola, Cristina (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Bueren, Juan (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Canals, Josep M. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Delgadillo Duarte, Joaquin (Banc de Sang i Teixits) ;
Delgado, Julio (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Eguizábal, Cristina (Instituto de Investigación Sanitaria Biocruces Bizkaia) ;
Fernández-Santos, María-Eugenia (Gregorio Marañón General University Hospital) ;
García-Olmo, Damián (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
González-Aseguinolaza, Gloria (Universidad de Navarra) ;
Juan, Manel (Hospital Clínic i Provincial de Barcelona) ;
Martín, Francisco (Universidad de Granada. Departamento de Bioquímica y Biología Molecular III e Inmunología) ;
Mata, Rosario (Coordination Unit of the Andalusian Network for the Design and Translation of Advanced Therapies) ;
Montserrat, Nuria (Institució Catalana de Recerca i Estudis Avançats) ;
Pérez-Martínez, Antonio (Universidad Autónoma de Madrid) ;
Pérez-Simón, José Antonio (Universidad de Sevilla. Department of Hematology) ;
Prosper, Felipe (Clínica Universidad de Navarra) ;
Urbano Ispizua, Álvaro (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Zapata, Agustín G. (Complutense University. Faculty of Biology. Dept of Cell Biology) ;
Sureda, Anna (Universitat de Barcelona. Departament d'hematologia) ;
Moraleda, José María (University of Murcia) ;
Universitat Autònoma de Barcelona
2023 - 10.1038/s41409-023-01962-0
Bone marrow transplantation, Vol. 58 (march 2023) , p. 727-728
|
|
|
5.
|
|
8 p, 1.8 MB |
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT) : an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
/
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Putter, Hein (Leiden University Medical Center) ;
Eikema, Dirk-Jan (EBMT Statistical Unit Leiden) ;
Busto, María Paula (EBMT Registry) ;
McGrath, Eoin (ICCBBA (Barcelona, Espanya)) ;
Middelkoop, Bas (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Adams, Gillian (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Atlija, Marina (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Ayuk, Francis (University Medical Center Hamburg) ;
Baldomero, Helen (University Hospital Basel (Basilea, Suïssa)) ;
Beguin, Yves (CHU of Liège and University of Liège) ;
de la Camara, Rafael (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Cedillo Cedillo, Angel (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) ;
Balari, Anna María Sureda (Hospital Universitari de Bellvitge) ;
Chabannon, Christian (Institut Paoli-Calmettes Comprehensive Cancer Centre) ;
Corbacioglu, Selim (University Children's Hospital Regensburg) ;
Dolstra, Harry (Radboud University Medical Center) ;
Duarte, Rafael (Universidad Autónoma de Madrid) ;
Duléry, Rémy (Sorbonne Université) ;
Greco, Raffaella (Autoimmune Diseases Working Party (Barcelona, Espanya)) ;
Gusi, Andreu (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Hamad, Nada (University of Notre Dame Australia) ;
Kenyon, Michelle (King's College Hospital NHS Foundation Trust) ;
Kroeger, Nicolaus (University Medical Center Hamburg) ;
Labopin, Myriam (European Society for Blood and Marrow Transplantation-EBMT Paris Study Office) ;
Lee, Julia (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Manson, Lynn (Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services (Regne Unit)) ;
Mensil, Florence (Agence de la Biomédecine) ;
Milpied, Noel (Centre Hospitalier Universitaire Bordeaux) ;
Mohty, Mohamad (Sorbonne University) ;
Oldani, Elena (Italian National BMT Registry) ;
Orchard, Kim (University Hospital Southampton NHS) ;
Passweg, Jakob (University Hospital Basel (Basilea, Suïssa)) ;
Pearce, Rachel (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
de Latour, Régis Peffault (BMT unit Paris Cité University) ;
Poirel, Hélène A. (Belgian Transplant Registry) ;
Rintala, Tuula (King's College Hospital NHS Foundation Trust) ;
Rizzo, J. Douglas (CIBMTR, Medical College of Wisconsin) ;
Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Sanchez-Martinez, Carla (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Sanchez-Guijo, Fermin (CIC-University of Salamanca) ;
Sánchez-Ortega, Isabel (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Trnková, Marie (Czech registry Czech Republic) ;
Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ;
Wilcox, Leonie (Australasian Bone Marrow Transplant Recipient Registry) ;
de Wreede, Liesbeth C. (Leiden University Medical Center) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Universitat Autònoma de Barcelona
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. [...]
2023 - 10.1038/s41409-023-01924-6
Bone marrow transplantation, march 2023, p. 1-8
|
|
|
6.
|
|
4 p, 336.0 KB |
Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice
/
Garcia-Gutierrez, Valentin (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ;
Luna, Alejandro (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ;
Alonso-Dominguez, Juan M. (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Estrada Barreras, Natalia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Boque, Concepcion (Institut Català d'Oncologia) ;
Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Giraldo, Pilar (Hospital Quirónsalud Zaragoza) ;
Angona, Anna (Institut Català d'Oncologia) ;
Álvarez Larrán, Alberto (Hospital Clínic i Provincial de Barcelona) ;
Sanchez-Guijo, Fermin (Instituto de Investigación Biomédica de Salamanca) ;
Ramírez, María José (Hospital Universitario de Jerez (Jerez de la Frontera)) ;
Mora, Elvira (Hospital Universitari i Politècnic La Fe (València)) ;
Vélez, Patricia (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Rosell, Ana (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Colorado Araujo, Mercedes (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Cuevas, Beatriz (Hospital Universitario de Burgos) ;
Sagüés, Miguel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Cortés, Montserrat (Hospital General de Granollers) ;
Pérez-Encinas, Manuel (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Casado Montero, Luis Felipe (Hospital Virgen de la Salud (Toledo)) ;
Moreno Vega, Melania (Hospital Doctor José Molina Orosa) ;
Serrano, Luis (Consorci Hospitalari Provincial de Castelló) ;
Gomez, Valle (Hospital Universitario de la Princesa (Madrid)) ;
Garcia-Hernandez, Carmen (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Lakhwani, Sunil (Hospital Universitario de Canarias (La Laguna)) ;
Paz Coll, Antonio (Hospital Universitario Puerto Real (Cadis)) ;
De Paz, Raquel (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) ;
Suarez-Varela, Sara (Hospital Universitario de Jerez (Jerez de la Frontera)) ;
Fernandez-Ruiz, Andrés (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Perez Lopez, Raul (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Ortiz-Fernández, Almudena (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ;
Jiménez-Velasco, Antonio (Hospital Regional Universitario de Málaga) ;
Steegmann-Olmedillas, Juan Luis (Hospital Universitario de la Princesa (Madrid)) ;
Hernandez-Boluda, Juan Carlos (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
2021 - 10.1038/s41408-021-00420-8
Blood Cancer Journal, Vol. 11 (february 2021)
|
|
|
7.
|
|
24 p, 2.3 MB |
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases : updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
/
Sharrack, Basil (NIHR Neurosciences Biomedical Research Centre. University of Sheffield) ;
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Alexander, Tobias (Charité - Universitätsmedizin Berlin) ;
Badoglio, Manuela (EBMT Paris study office. Department of Haematology. Saint Antoine Hospital. INSERM UMR 938. Sorbonne University) ;
Burman, Joachim (Department of Neuroscience. Uppsala University) ;
Farge-Bancel, Dominique (EA 3518. Université Denis Diderot) ;
Greco, Raffaella (IRCCS San Raffaele Scientific Institute (Milà, Itàlia). Hematology and Bone Marrow Transplantation Unit) ;
Jessop, Helen (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Kazmi, Majid (King's College Hospital NHS Foundation Trust) ;
Kirgizov, Kirill Igorevich (N.N. Blokhin National Medical Center of Oncology. Institute of Pediatric Oncology and Hematology) ;
Labopin, Myriam (EBMT Paris study office. Department of Haematology. Saint Antoine Hospital. INSERM UMR 938. Sorbonne University) ;
Mancardi, Giovanni Luigi (University of Genova and Clinical Scientific Institutes Maugeri. Department of Neuroscience) ;
Martin, Roland (University Hospital Zurich (Suïssa)) ;
Moore, John (St. Vincent's Health Network. Haematology Department.) ;
Muraro, Paolo Antonio (Imperial College London) ;
Rovira Tarrats, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Sormani, Maria Pia (IRCCS Ospedale Policlinico San Martino) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Snowden, John A (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
McGrath, Eoin (EBMT Executive Office) ;
Bambi, Franco (Ospedale Pediatrico. Azienda Ospedaliero Universitaria Meyer (A.O.U. Meyer)) ;
Sanchez-Guijo, Fermin (Instituto de Investigación Biomédica de Salamanca) ;
Worel, Nina (Blood Group Serology and Transfusion Medicine. Medical University of Vienna) ;
Abinun, Mario (Great North Children's Hospital. Institute of Cellular Medicine. Newcastle University) ;
Arnold, Renate (Charité - Universitätsmedizin Berlin) ;
Brierley, Charlotte (Oxford University Hospitals NHS Foundation Trust) ;
Castilla-Llorente, Cristina (Unité de transplantation des cellules souches. Département d'Hématologie Gustave Roussy) ;
Cooper, Nichola (Hammersmith Hospital (Londres)) ;
Daikeler, Thomas D. (University Hospital Basel (Basilea, Suïssa)) ;
del Papa, Nicoletta (Ospedale Gaetano Pini. Department of Rheumatology) ;
Farge-Bancel, Dominique (EA 3518. Université Denis Diderot) ;
Finke, Jürgen M. (Department of Medicine-Hematology and Oncology. University of Freiburg) ;
Hagglund, Hans G. (Department of Hematology. Uppsala University Hospital) ;
Henes, Jörg Christoph (University Hospital of Tübingen (Alemanya)) ;
Hiepe, Falk (Charité - Universitätsmedizin Berlin) ;
Kiely, David G. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Marjanovic, Z. (Department of Haematology. Saint Antoine Hospital) ;
Martin, Roland (Neuroimmunology and MS Research. Neurology Clinic. University Hospital) ;
Martin, Thierry (Department of Clinical Immunology. National Referral Center for Autoimmune Diseases. Strasbourg University Hospital) ;
Ma, D. (Haematology Department. St. Vincent's Health Network) ;
Moore, J. (Haematology Department. St. Vincent's Health Network) ;
Miller, P. (Anthony Nolan Research Institute) ;
Muraro, P. (Imperial College London) ;
Oliveira, M. C. (Division of Clinical Immunology. Ribeirão Preto Medical School. University of São Paulo) ;
Polushin, A. (Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology. Hematology and Transplantation First State Pavlov Medical University of Saint Petersburg) ;
Onida, F. (Haematology-BMT Centre. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Università degli Studi di Milano) ;
Simoes, B. (Division of Hematology. Ribeirão Preto Medical School. University of São Paulo) ;
Puyade, M. (Centre Hospitalier Universitaire de Poitiers) ;
Resnick, I. (University Hospital St. Marina) ;
Rovira Argelagués, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Saccardi, R. (Careggi University Hospital (Florència, Itàlia)) ;
Saif, M. (Department of Clinical Haematology. Manchester Royal Infirmary) ;
Sakellari, Ioanna (Bone Marrow Transplantation Unit. George Papanicolaou General Hospital) ;
Sharrack, B. (NIHR Neurosciences Biomedical Research Centre. University of Sheffield) ;
Snarski, E. (Department of Hematology. Oncology and Internal Medicine. Medical University of Warsaw) ;
Scherer, H. U. (Department of Rheumatology. Leiden University Medical Centre) ;
Sossa, C. (Division of Hematology and Hematopoietic Stem Cell Transplantation. Hematology and Stem Cell Transplantation Unit. Clinica FOSCAL) ;
de Vries-Bouwstra, J. (Department of Rheumatology. Leiden University Medical Centre) ;
Wulffraat, N. (Divisie Kinderen. Cluster Immunologie. Reumatologie. Hematologie en Infectiologie. Wilhelmina Kinderziekenhuis) ;
Zaccara, E. (Osp. G. Pini. Department of Rheumatology) ;
Universitat Autònoma de Barcelona
These updated EBMT guidelines review the clinical evidence, registry activity and mechanisms of action of haematopoietic stem cell transplantation (HSCT) in multiple sclerosis (MS) and other immune-mediated neurological diseases and provide recommendations for patient selection, transplant technique, follow-up and future development. [...]
2020 - 10.1038/s41409-019-0684-0
Bone marrow transplantation, Vol. 55 Núm. 2 (january 2020) , p. 283-306
|
|
|
8.
|
|
10 p, 398.8 KB |
Acceptability and feasibility of a virtual community of practice to primary care professionals regarding patient empowerment : A qualitative pilot study
/
Bermejo-Caja, Carlos Jesús (Universidad Autónoma de Madrid. Departamento de Enfermería) ;
Koatz, Débora (Universitat Autònoma de Barcelona. Institut Universitari Avedis Donabedian) ;
Orrego, Carola (Universitat Autònoma de Barcelona. Institut Universitari Avedis Donabedian) ;
Perestelo-Pérez, Lilisbeth (Servicio de Evaluación y Planificación. Dirección Del Servicio Canario de la Salud. Centro de Salud El Chorrillo) ;
González-González, Ana Isabel (Centro de Salud Vicente Muzas. Gerencia Asistencial de Atención Primaria. Servicio Madrileño de Salud) ;
Ballester, Marta (Universitat Autònoma de Barcelona. Institut Universitari Avedis Donabedian) ;
Pacheco Huergo, Valeria (EAP Turó) ;
del Rey-Granado, Yolanda (Unidad de Apoyo Técnico. Gerencia Asistencial de Atención Primaria. Servicio Madrileño de Salud) ;
Muñoz-Balsa, M. (Unidad de Apoyo Técnico. Gerencia Asistencial de Atención Primaria. Servicio Madrileño de Salud) ;
Ramírez-Puerta, Ana Belén (Unidad de Apoyo Técnico. Gerencia Asistencial de Atención Primaria. Servicio Madrileño de Salud) ;
Canellas-Criado, Yolanda (Centro de Salud Monóvar. Gerencia Asistencial de Atención Primaria. Servicio Madrileño de Salud) ;
Pérez-Rivas, Francisco-Javier (Universidad Complutense de Madrid. Departamento de Enfermería) ;
Toledo-Chávarri, Ana (Fundación Canaria de Investigación Sanitaria. Centro de Salud El Chorrillo) ;
Martínez-Marcos, Mercedes (Universidad Autónoma de Madrid. Departamento de Enfermería) ;
Alejo-Díaz-Zorita, Concepcion ;
Barbero-Macías, Cynthia A. ;
Borrell-Punzón, Fernando ;
Bueno-Rodriguez, Beatriz ;
Colmena-Martin, Begona ;
Del Valle-De Joz, Isabel ;
Gamboa-Puñal, Juan Carlos ;
García-Valverde, Concepcion ;
Gómez-Garzón, Luis Miguel ;
Gómez-López, Arturo ;
Hernaz-Guijo, Alejandro ;
Herrera-León, Walter Nery ;
Iniesta-González, Irene ;
Leza-Leza, Margarita ;
Melchor-Canelo, Maria Aranzazu ;
Muñoz-Quirós-Aliaga, Sagrario ;
Oria-Fernández, Ángela ;
Pertierra-Galindo, Nuria ;
Prieto-Barbosa, Maria Dolores ;
Robledo-Vázquez, Milagros ;
Ruiz-López, Marta ;
Sánchez-Cruz, M. Carmen ;
Sánchez-De-Eusebio, M. Ángeles ;
Seijas-Martínez-Echevarría, Maria Jose ;
Tovar-García, Carmen Paola ;
Vicente-Diez, José Ignacio ;
Villanueva-Sanz, Cristina ;
Universitat Autònoma de Barcelona
Background: Virtual communities of practice (vCoPs) facilitate online learning via the exchange of experiences and knowledge between interested participants. Compared to other communities, vCoPs need to overcome technological structures and specific barriers. [...]
2019 - 10.1186/s12913-019-4185-z
BMC health services research, Vol. 19 Núm. 1 (20 2019) , p. 403
|
|
|
9.
|
|
11 p, 2.0 MB |
Immediate effects of dasatinib on the migration and redistribution of naïve and memory lymphocytes associated with lymphocytosis in chronic myeloid leukemia patients
/
Colom-Fernández, B. (Instituto de Investigación Hospital Universitario de la Princesa) ;
Kreutzman, A. (Instituto de Investigación Hospital Universitario de la Princesa) ;
Marcos-Jiménez, A. (Instituto de Investigación Hospital Universitario de la Princesa) ;
Garcia-Gutierrez, Valentin (Hospital Universitario Ramón y Cajal (Madrid)) ;
Cuesta-Mateos, C. (Instituto de Investigación Hospital Universitario de la Princesa) ;
Portero-Sainz, I. (Instituto de Investigación Hospital Universitario de la Princesa) ;
Pérez-García, Yaiza (Instituto de Investigación Hospital Universitario de la Princesa) ;
Casado Montero, Luis Felipe (Hospital Virgen de la Salud (Toledo)) ;
Sánchez-Guijo, F. (Instituto de Investigación Biomédica de Salamanca) ;
Martínez-López, J. (Hospital Universitario 12 de Octubre (Madrid)) ;
Ayala, Rosa (Hospital Universitario 12 de Octubre (Madrid)) ;
Boque, Concepcion (Institut Català d'Oncologia) ;
Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Montero, I. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Soto, C. (Servicio de Hematología. Hospital Povisa) ;
Paz, R. (Hospital Universitario La Paz (Madrid)) ;
Silva, G. (Instituto de Investigación Hospital Universitario de la Princesa) ;
Vega-Piris, L. (Instituto de Investigación Hospital Universitario de la Princesa) ;
Steegmann, J. L. (Instituto de Investigación Hospital Universitario de la Princesa) ;
Muñoz Calleja, Cecilia (Instituto de Investigación Hospital Universitario de la Princesa) ;
Universitat Autònoma de Barcelona
Introduction: Dasatinib is a dual SRC/ABL tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML) that is known to have unique immunomodulatory effects. In particular, dasatinib intake typically causes lymphocytosis, which has been linked to better clinical response. [...]
2019 - 10.3389/fphar.2019.01340
Frontiers in Pharmacology, Vol. 10 (2019) , p. 1340
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
